Literature DB >> 6780608

Duration and characteristics of treatment of premature lambs with natural surfactant.

A Jobe, M Ikegami, T Glatz, Y Yoshida, E Diakomanolis, J Padbury.   

Abstract

Premature lambs were treated with 50 mg/kg of natural surfactant lipid by tracheal instillation either at birth or shortly thereafter when respiratory failure was documented. All lambs were delivered by cesarean section and supported on infant ventilators with 100% oxygen under conditions to mimic the care of human infants with the respiratory distress syndrome. The natural surfactant used for therapy was recovered by lavage from sheep lung. Six 120-d gestational age lambs treated at birth had an initial mean oxygen pressure (pO2) value of 270 +/- 35 mm Hg; this fell within 3 h to less than 100 mm Hg. By 8.3 +/- 0.3 h after birth the lambs were in severe respiratory failure with a mean pH less than 7.1 and a mean pCO2 greater than 70 mm Hg. Six untreated lambs had pH values below 7.0 within 40 min of life despite more intensive respiratory support than was given the treated animals. Treatment with natural surfactant of 17 lambs of 120 and 130 d gestational age after early respiratory failure resulted in a prompt increase in pO2 values from about 35 mm Hg to values over 200 mm Hg and a fall in pCO2 values to normal levels in the majority of animals. This response lasted only approximately 3 h, and a second treatment was less predictably effective.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6780608      PMCID: PMC370577          DOI: 10.1172/JCI110044

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  18 in total

1.  PATHOPHYSIOLOGY OF RESPIRATORY DISTRESS IN NEWBORN LAMBS. CIRCULATORY, BIOCHEMICAL, AND PATHOLOGICAL CONSIDERATIONS.

Authors:  M STAHLMAN; V S LEQUIRE; W C YOUNG; R E MERRILL; R T BIRMINGHAM; G A PAYNE; J GRAY
Journal:  Am J Dis Child       Date:  1964-10

2.  SURFACE PROPERTIES AND LIPIDS FROM LUNGS OF INFANTS WITH HYALINE MEMBRANE DISEASE.

Authors:  F H ADAMS; T FUJIWARA; G EMMANOUILIDES; A SCUDDER
Journal:  J Pediatr       Date:  1965-02       Impact factor: 4.406

3.  Phosphorus assay in column chromatography.

Authors:  G R BARTLETT
Journal:  J Biol Chem       Date:  1959-03       Impact factor: 5.157

4.  Surface properties in relation to atelectasis and hyaline membrane disease.

Authors:  M E AVERY; J MEAD
Journal:  AMA J Dis Child       Date:  1959-05

5.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

6.  Surface active materials from dog lung. II. Composition and physiological correlations.

Authors:  R J King; J A Clements
Journal:  Am J Physiol       Date:  1972-09

7.  Labeling of phospholipids in the surfactant and subcellular fractions of rabbit lung.

Authors:  A Jobe; E Kirkpatrick; L Gluck
Journal:  J Biol Chem       Date:  1978-06-10       Impact factor: 5.157

8.  The quantity of natural surfactant necessary to prevent the respiratory distress syndrome in premature lambs.

Authors:  M Ikegami; F H Adams; B Towers; A B Osher
Journal:  Pediatr Res       Date:  1980-09       Impact factor: 3.756

9.  Neonatal pulmonary ischemia. I. Clinical and physiological studies.

Authors:  J Chu; J A Clements; E K Cotton; M H Klaus; A Y Sweet; W H Tooley; B L Bradley; L C Brandorff
Journal:  Pediatrics       Date:  1967-10       Impact factor: 7.124

10.  Restoration of lung pressure-volume characteristics with surfactant: comparison of nebulization versus instillation and natural versus synthetic surfactant.

Authors:  M Ikegami; T Hesterberg; M Nozaki; F H Adams
Journal:  Pediatr Res       Date:  1977-03       Impact factor: 3.756

View more
  23 in total

Review 1.  Neonatal non-invasive respiratory support: physiological implications.

Authors:  Thomas H Shaffer; Deepthi Alapati; Jay S Greenspan; Marla R Wolfson
Journal:  Pediatr Pulmonol       Date:  2012-07-06

2.  Acute effects of instillation of surfactant in severe respiratory distress syndrome.

Authors:  H L Halliday; F B McCord; B G McClure; M M Reid
Journal:  Arch Dis Child       Date:  1989-01       Impact factor: 3.791

Review 3.  Chronic lung disease in the preterm infant. Lessons learned from animal models.

Authors:  Anne Hilgendorff; Irwin Reiss; Harald Ehrhardt; Oliver Eickelberg; Cristina M Alvira
Journal:  Am J Respir Cell Mol Biol       Date:  2014-02       Impact factor: 6.914

4.  Response to bovine surfactant (surfactant TA) in two different HMD models (lambs and baboons).

Authors:  H Maeta; D Vidyasagar; T Raju; R Bhat; H Matsuda
Journal:  Eur J Pediatr       Date:  1988-02       Impact factor: 3.183

5.  Enterobacter agglomerans lipopolysaccharide-induced changes in pulmonary surfactant as a factor in the pathogenesis of byssinosis.

Authors:  A J DeLucca; K A Brogden; R Engen
Journal:  J Clin Microbiol       Date:  1988-04       Impact factor: 5.948

6.  Appropriate surfactant usage in 1996.

Authors:  R F Soll
Journal:  Eur J Pediatr       Date:  1996-08       Impact factor: 3.183

Review 7.  Surfactant replacement therapy.

Authors:  M J Kresch; W H Lin; R S Thrall
Journal:  Thorax       Date:  1996-11       Impact factor: 9.139

8.  Alveolar liquid pressure measured by micropuncture in isolated lungs of mature and immature fetal rabbits.

Authors:  J U Raj
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

Review 9.  Surfactant treatment for respiratory distress syndrome: a review.

Authors:  C J Morley
Journal:  J R Soc Med       Date:  1984-09       Impact factor: 5.344

10.  Surfactant and pulmonary blood flow distributions following treatment of premature lambs with natural surfactant.

Authors:  A Jobe; M Ikegami; H Jacobs; S Jones
Journal:  J Clin Invest       Date:  1984-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.